Kimberley Frutoz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Biologics have emerged as a powerful and diverse class of molecular and cell-based therapies that are capable of replacing enzymes, editing genomes, targeting tumors, and more. As this complex array of tools arises a distinct set of challenges is rarely encountered in the development of small molecule therapies. Biotherapeutics tend to be big, bulky, polar(More)
  • 1